Selected article for: "risk population and viral infection"
Author: Tripathy, Archana; Swain, Nitish; Gupta, Bhawna
Title: The COVID-19 pandemic: an increased risk of rheumatoid arthritis
  • Cord-id: 5qier16x
  • Document date: 2021_6_22
    • ID: 5qier16x
    Snippet: COVID-19 is a respiratory infection similar to viral pneumonia and is caused by SARS-CoV-2. Chloroquine and hydroxychloroquine make up the major part of the treatment regimen for the management of COVID-19 infections, which are also commonly used in treatment of patients with malaria as well as autoimmune diseases like rheumatoid arthritis (RA). In this review, we analyzed the scientific evidences pertaining to any possible association of SARS-CoV-2 infection with RA. We thus believe that people
    Document: COVID-19 is a respiratory infection similar to viral pneumonia and is caused by SARS-CoV-2. Chloroquine and hydroxychloroquine make up the major part of the treatment regimen for the management of COVID-19 infections, which are also commonly used in treatment of patients with malaria as well as autoimmune diseases like rheumatoid arthritis (RA). In this review, we analyzed the scientific evidences pertaining to any possible association of SARS-CoV-2 infection with RA. We thus believe that people predisposed to RA carry a higher infection risk than the general population both due to the iatrogenic effects of the RA related drug therapy. Thus COVID-19 pandemic may bring a higher risk of health emergency in complex diseases such as RA.

    Search related documents:
    Co phrase search for related documents
    • activator signal transducer and lung disease: 1, 2, 3, 4, 5
    • activator signal transducer and lung function: 1, 2, 3
    • acute pain and long period: 1, 2
    • acute pain and lung disease: 1, 2, 3, 4
    • acute pain and lung function: 1
    • long period and lung disease: 1, 2
    • long period and lung function: 1, 2, 3
    • losartan treatment and lung damage: 1
    • lung damage and lymphocyte activation: 1, 2
    • lung damage and macrophage inflammatory protein: 1, 2
    • lung disease and lymphocyte activation: 1, 2
    • lung disease and macrophage inflammatory protein: 1, 2
    • lung function and lymphocyte activation: 1
    • lung function and macrophage inflammatory protein: 1, 2, 3, 4